Skip to main content

Next-Generation Vaccines Eradicating Chronic and Infectious Diseases


The growing prevalence of chronic and infectious disorders such as cancer, and diabetes, globally has emerged as the biggest concerns that the medical industry faces today. There have been continuous attempts to develop improved treatment procedures for such diseases.
Vaccines have been one of the most effective methods for the treatment and prevention of diseases. The invention of DNA, recombinant, and cancer vaccines, and advancements in the platform for vaccine delivery have transformed the conventional therapeutic and preventive vaccines and are playing an important role in the treatment of such chronic diseases.
At present, the vaccine market is in its growing stage, however as per the market intelligence report published by BIS Research titled “Global Vaccine Market – Analysis and Forecast (2018 – 2028),” the vaccine market is anticipated to witness tremendous growth at 11.0% during the forecast period, 2018 – 2028 and generate $103.57 billion in the revenue by 2028.
This high growth of the market can be attributed to the increasing incidences of chronic diseases, growing adoption of vaccines across developed as well as developing countries, and the invention of advanced techniques and technologies.  Amongst the long list of advantages of vaccines, the reduced healthcare cost and improved life expectancy rate are their major benefits.
Several leading pharmaceutical companies are venturing in the market, some of these include Abbott Laboratories, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Merck & Company Inc., and Madison Vaccines Incorporated.
The report published by BIS Research discusses the vaccine market under different segments on the basis of type, disease type, and region. Under the vaccine type, there are subunit and conjugate, live attenuated, inactivated, recombinant, toxoid, and next-generation vaccines. Moreover, the disease type segment includes cancer, hepatitis, rotavirus, varicella, and influenza, among others.
Under the region segment, the report analyzes the market for North America, Europe, Asia-Pacific, Latin America, and Middle East Africa. Amongst these, Asia-Pacific region is expected to grow at the fastest CAGR during the forecast period.
With technological advancements in the medical industry, vaccines for multiple cancers such as gastric, ovarian, melanoma, and prostate cancer have already been developed and several companies at present are focusing to develop next-generation vaccines. The global vaccine market in the coming years is expected to evolve and undergo various developments and advancements.

Comments

Post a Comment

Popular posts from this blog

Personal Care Ingredients Market Size, Share & Trends Analysis Report 2019-2029

The introduction and proliferation of bio-based ingredients in several industries, such as food and beverage, pharmaceuticals, and cosmetics, has been transforming the manufacturing landscape since 2000. Growing consumer inclination toward the adoption of bio-based products due to rising health and environmental concerns is driving the demand for bio-based ingredients in the cosmetics and personal care products. Besides, awareness among consumers regarding the harmful effects of synthetic ingredients chemicals has grown rapidly over the past years. In addition, the availability of green raw materials has also urged large cosmetic firms to develop bio-based cosmetic products. However, limited availability of raw material, due to erratic weather conditions and stringent environmental regulations, can pose substantial hurdles in the production of bio-based ingredients. Thus, leading companies have been focusing on developing new and sustainable ways of producing the ingredi...
Post a Comment
Read more

Strategies Incorporated to Sustain the Competition

  The strategies followed by various prominent companies to sustain the competition and expand their market share has been varying from mergers and acquisitions (M&A) to collaborations and partnerships. In the past three years (January 2017-September 2020), the market witnessed approximately eight M&A activities, seven partnerships, and alliances (collaborations, joint ventures, and other agreements), one business expansion, and four other developments. Among the different key developments, M&A activities constitute the dominant contributor’s strategies, followed by partnership and alliances. The global bioengineered skin substitutes market is dominated by juggernauts including AbbVie, Inc., Integra LifeSciences Corporation, Smith & Nephew plc, and Stryker Corporation, and other medium and small-medium enterprises that are offering wide ranges of bioengineered skin substitute products in the market. Several companies are attempting to enter the market and sustain...
Post a Comment
Read more

Increasing Adoption of Lidar in Construction Applications

  The construction industry is continuously growing and has been witnessing various technological innovations. The construction industry depicts high complexity, steep costs, and low toleration for error, that facilitate the adoption of laser scanning. Lidars have enabled the construction industry to gain 3D models of existing space and build digital plans on those real spaces. Digital collaboration frameworks such as building information modelling (BIM) deliver the value of the scans to every element of a construction team in formats that are best suited to their needs. BIM schematics also provide continuing value to facility maintenance and operation teams. BIS Research Report on Lidar Market Numerous stages of construction projects are scanned for quality assurance, cross-checking with models, and spotting errors. Lidars can also be deployed for quality evaluation of prefabricated materials, allowing an efficient, and cheap evaluation. Furthermore, lidars find applications i...
Post a Comment
Read more